Internal Medicine, Endocrinology, Diabetes, & Metabolism · West Nyack, NY
NPI
1912056623
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2 Centerock Rd
West Nyack, NY, 10994
Phone (845) 703-6999
Groups this clinician bills Medicare through
Medicare paid, 2024
$174K
6,640 services
Medicare patients, 2024
396
Average age 71
Drug cost, 2024
$2.5M
5,278 prescriptions
Company payments, 2025
$13.79
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Grace Y Kang was code J0897 (injection, denosumab, 1 mg), 2,760 times for 31 patients. In total Grace Y Kang billed 6,640 services in 62 codes, and Medicare paid $174K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 2,760 | 31 | $20.70 | $57K |
| 99214 Office E&M - Established | Office | 656 | 311 | $102.82 | $67K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 585 | 313 | $14.20 | $8,309 |
| 36415 Venipuncture Blood Collection | Office | 500 | 266 | $8.63 | $4,317 |
| 80053 Clinical Chemistry | Office | 276 | 170 | $10.35 | $2,857 |
| 84443 Clinical Chemistry | Office | 266 | 176 | $16.46 | $4,378 |
| 83036 Blood Count | Office | 248 | 152 | $9.52 | $2,361 |
| 80061 Clinical Chemistry | Office | 245 | 152 | $13.12 | $3,214 |
| 82306 Clinical Chemistry | Office | 135 | 97 | $29.01 | $3,916 |
| 82043 Clinical Chemistry | Office | 130 | 98 | $5.66 | $736 |
| 82570 Clinical Chemistry | Office | 129 | 98 | $5.08 | $655 |
| 85025 Blood Count | Office | 124 | 92 | $7.61 | $944 |
| 99213 Office E&M - Established | Office | 67 | 52 | $72.16 | $4,835 |
| 84439 Clinical Chemistry | Office | 61 | 46 | $8.84 | $539 |
| 85027 Blood Count | Office | 59 | 51 | $6.34 | $374 |
By year: 2022 $164K for 7,213 services; 2023 $161K for 6,282 services; 2024 $174K for 6,640 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 500 | 266 | $8.63 | $4,317 |
| 80053 Clinical Chemistry | 276 | 170 | $10.35 | $2,857 |
| 84443 Clinical Chemistry | 266 | 176 | $16.46 | $4,378 |
| 83036 Blood Count | 248 | 152 | $9.52 | $2,361 |
| 80061 Clinical Chemistry | 245 | 152 | $13.12 | $3,214 |
| 82306 Clinical Chemistry | 135 | 97 | $29.01 | $3,916 |
| 82043 Clinical Chemistry | 130 | 98 | $5.66 | $736 |
| 82570 Clinical Chemistry | 129 | 98 | $5.08 | $655 |
| 85025 Blood Count | 124 | 92 | $7.61 | $944 |
| 84439 Clinical Chemistry | 61 | 46 | $8.84 | $539 |
Medicare prescription drug claims, 2024
In 2024, the drug Grace Y Kang prescribed most often to Medicare patients was Levothyroxine Sodium, with 551 prescriptions and refills. In total Grace Y Kang wrote 5,278 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 551 | 1,451 | 146 | $5,679 |
| Ozempic Semaglutide | 465 | 853 | 112 | $818K |
| Metformin Hcl Generic | 357 | 849 | 93 | $2,196 |
| Glipizide Generic | 329 | 814 | 92 | $2,167 |
| Metformin Hcl Er Metformin Hcl | 298 | 720 | 83 | $3,540 |
| Jardiance Empagliflozin | 265 | 519 | 67 | $303K |
| Atorvastatin Calcium Generic | 184 | 491 | 58 | $1,349 |
| Mounjaro Tirzepatide | 183 | 261 | 66 | $278K |
| Farxiga Dapagliflozin Propanediol | 133 | 259 | 45 | $145K |
| Alendronate Sodium Generic | 128 | 294 | 42 | $912 |
| Pioglitazone Hcl Generic | 118 | 301 | 29 | $675 |
| Rosuvastatin Calcium Generic | 106 | 281 | 34 | $1,592 |
| Januvia Sitagliptin Phosphate | 103 | 199 | 25 | $108K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 102 | 273 | 50 | $8,577 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 86 | 238 | 40 | $9,700 |
Brand drugs: 2,243 claims; generic drugs: 2,795 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Grace Y Kang $13.79 ($13.79 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $13.79.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $13.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.